KYMR Competitors & Alternatives
Compare Kymera Therapeutics Inc with similar stocks in the same industry
Biotechnology
KYMR
Main Stock$119.80
Tradestie Score
38
Market Cap
$3.91B
Revenue Growth
4.7%
Analyst Upside
+9.3%
Top Competitors
237 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
EXEL
Exelixis Inc
|
$54.08
|
$11.09B | 16.9 | 52 | Compare |
|
ROIV
Roivant Sciences Ltd. Common Shares
|
$36.30
|
$10.76B | - | 48 | Compare |
|
MRNA
Moderna, Inc. Common Stock
|
$145.13
|
$10.74B | - | 40 | Compare |
|
BMRN
BioMarin Pharmaceuticals Inc
|
$66.70
|
$10.53B | 188.0 | 42 | Compare |
|
IONS
Ionis Pharmaceuticals, Inc. Common Stock
|
$59.74
|
$10.49B | - | 40 | Compare |
|
BBIO
BridgeBio Pharma, Inc. Common Stock
|
$81.50
|
$10.22B | - | 52 | Compare |
|
MDGL
Madrigal Pharmaceuticals, Inc. Common Stock
|
$516.74
|
$10.01B | - | 51 | Compare |
|
TECH
Bio-Techne Corp.
|
$72.32
|
$9.33B | 61.9 | 51 | Compare |
|
CORT
Corcept Therapeutics Inc.
|
$122.25
|
$8.88B | 263.2 | 40 | Compare |
|
HALO
Halozyme Therapeutics, Inc.
|
$108.17
|
$8.77B | 31.6 | 35 | Compare |
More KYMR Analysis
Data updated: Aug 23, 2026 | Industry: Biotechnology (SIC 2836)
237 stocks in this industry